Rhythm Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Rhythm Pharmaceuticals, Inc. (RYTM)
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.rhythmtx.com
Company Research
Source: Yahoo! Finance
Rhythm Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Execution and Commercial Momentum Full-year 2025 revenue reached $194.8 million, an increase of approximately 50% from 2024, driven by a 10% global increase in patients on reimbursed therapy and steady growth in international markets. Management attributed the 12% sequential revenue increase—growing from $51.3 million in Q3 to $57.3 million in Q4—to a 10% global rise in patients on reimbursed therapy, which was partially offset by a negative $1.3 million inventory swing at U.S. specialty pharmacies. The U.S. sales force expansion from 16 to 42 personnel is complete, focusing on identifying approximately 10,000 potential Acquired HO patients ahead of the March 20th PDUFA date. Phase 2 bivamelagon data in HO demonstrated BMI reductions of 14.3% at 40 weeks for the 600mg cohort, reinforcing the drug's potential as a potent oral alternative to setmelanotide. Strategic positioning in Japan is accelerat
Show less
Read more
Impact Snapshot
Event Time:
RYTM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RYTM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RYTM alerts
High impacting Rhythm Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
RYTM
News
- Rhythm Pharmaceuticals (RYTM) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..MarketBeat
- Rhythm Pharmaceuticals price target lowered to $110 from $125 at H.C. Wainwright [Yahoo! Finance]Yahoo! Finance
- Rhythm Pharmaceuticals (RYTM) had its price target lowered by Canaccord Genuity Group Inc. from $141.00 to $140.00. They now have a "buy" rating on the stock.MarketBeat
- Rhythm Pharmaceuticals (RYTM) had its price target lowered by HC Wainwright from $125.00 to $110.00. They now have a "buy" rating on the stock.MarketBeat
- A Look At Rhythm Pharmaceuticals (RYTM) Valuation After Recent Pullback In Share Price [Yahoo! Finance]Yahoo! Finance
RYTM
Earnings
- 2/26/26 - Beat
RYTM
Sec Filings
- 3/4/26 - Form 4
- 3/4/26 - Form 144
- 3/3/26 - Form 4
- RYTM's page on the SEC website